WithdrawnPHASE1, PHASE2NCT05218408

CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type

Studying Giant cell glioblastoma

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Celularity Incorporated
Principal Investigator: Adrian Kilcoyne, MD
Celularity inc
Intervention: CYNK-001 systemic and Intra cavity administration(biological)
Eligibility: 18 years · All sexes
Timeline: 2022 – 2024

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05218408 on ClinicalTrials.gov

Other trials for Giant cell glioblastoma

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE1NCT06176066
PH Sensitive MRI Based Resections of Glioblastoma
University of California, Los Angeles
RECRUITINGNCT05864976
Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning
Washington University School of Medicine
ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT05685004
Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)
TVAX Biomedical
ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04922723
Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma
West Virginia University
RECRUITINGPHASE1NCT05083754
Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
ACTIVE NOT RECRUITINGPHASE1NCT04968366
Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery
Beijing Tiantan Hospital
ACTIVE NOT RECRUITINGPHASE2NCT04574856
Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma
University of Michigan Rogel Cancer Center
ACTIVE NOT RECRUITINGPHASE2NCT04116411
A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients
Cecilia Soderberg-Naucler

See all trials for Giant cell glioblastoma →

← Back to all trials